Musculoskeletal adverse events induced by immune checkpoint inhibitors: a large-scale pharmacovigilance study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hao,Liu

第一单位： Department of Orthopedics, Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.

作者： Hao,Liu ^[1] ; Yumin,Li ^[2] ; Jie,Li ^[1] ; Qiongchi,Zhang ^[1] ; Jingtao,Wu ^[1] ; Xinyu,Li ^[1] ; Liesu,Meng ^[3] ; Shuai,Cao ^[2] ; Haopeng,Li ^[1]

作者单位： Department of Orthopedics, Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China. ^[1] Department of Orthopedics, Civil Aviation General Hospital, Beijing, China. ^[2] National Joint Engineering Research Center of Biodiagnostics and Biotherapy, Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China. ^[3]

关键词 clinical characteristics combination therapy comorbidity immune checkpoint inhibitors musculoskeletal adverse events toxicity profile

DOI 10.3389/fphar.2023.1199031

PMID 37881181

发布时间 2023-10-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2023年14卷

1199031页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Musculoskeletal adverse events induced by immune checkpoint inhibitors: a large-scale pharmacovigilance study.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Musculoskeletal adverse events induced by immune checkpoint inhibitors: a large-scale pharmacovigilance study.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除